| Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 543 | 2019 |
| Documento de la Sociedad Española de Nefrología sobre las guías KDIGO para la evaluación y el tratamiento de la enfermedad renal crónica M Gorostidi, R Santamaría, R Alcázar, G Fernández-Fresnedo, ... Nefrología (Madrid) 34 (3), 302-316, 2014 | 442 | 2014 |
| Prevalencia de enfermedad renal crónica en España: impacto de la acumulación de factores de riesgo cardiovascular M Gorostidi, M Sánchez-Martínez, LM Ruilope, A Graciani, JJ de la Cruz, ... Nefrología 38 (6), 606-615, 2018 | 259 | 2018 |
| Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease M Gorostidi, R Santamaria, R Alcazar, G Fernandez-Fresnedo, ... Nefrología (English Edition) 34 (3), 302-316, 2014 | 109 | 2014 |
| Guía práctica sobre el diagnóstico y tratamiento de la hipertensión arterial en España, 2022. Sociedad Española de Hipertensión-Liga Española para la Lucha contra la … M Gorostidi, T Gijón-Conde, A De la Sierra, E Rodilla, E Rubio, E Vinyoles, ... Hipertensión y riesgo vascular 39 (4), 174-194, 2022 | 105 | 2022 |
| Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factors M Gorostidi, M Sánchez-Martínez, LM Ruilope, A Graciani, JJ de La Cruz, ... Nefrología (English Edition) 38 (6), 606-615, 2018 | 103 | 2018 |
| Cinacalcet reduces the set point of the PTH-calcium curve C Valle, M Rodriguez, R Santamaría, Y Almaden, ME Rodriguez, S Can, ... Journal of the American Society of Nephrology 19 (12), 2430-2436, 2008 | 89 | 2008 |
| Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans S Can, A Canalejo, R Santamaría, ME Rodríguez, JC Estepa, ... Journal of the American Society of Nephrology 16 (7), 2190-2197, 2005 | 81 | 2005 |
| Klotho/FGF23 and Wnt signaling as important players in the comorbidities associated with chronic kidney disease JR Muñoz-Castañeda, C Rodelo-Haad, MV Pendon-Ruiz de Mier, ... Toxins 12 (3), 185, 2020 | 78 | 2020 |
| Cytometric bead array (CBA) for the measurement of cytokines in urine and plasma of patients undergoing renal rejection R Jiménez, R Ramírez, J Carracedo, M Agüera, D Navarro, R Santamaría, ... Cytokine 32 (1), 45-50, 2005 | 69 | 2005 |
| Programa de habilidades en lectura crítica español (CASPe) RS Olmo NefroPlus 9 (1), 100-101, 2017 | 68 | 2017 |
| Fabry nephropathy: an evidence-based narrative review M Del Pino, A Andrés, AÁ Bernabéu, J de Juan-Rivera, E Fernández, ... Kidney and Blood Pressure Research 43 (2), 406-421, 2018 | 67 | 2018 |
| FGF23, biomarker or target? C Rodelo-Haad, R Santamaria, JR Muñoz-Castañeda, ... Toxins 11 (3), 175, 2019 | 64 | 2019 |
| Increased phosphaturia accelerates the decline in renal function: a search for mechanisms R Santamaría, JM Díaz-Tocados, MV Pendón-Ruiz de Mier, A Robles, ... Scientific reports 8 (1), 13701, 2018 | 57 | 2018 |
| Necrotizing glomerulonephritis and pulmonary hemorrhage associated with carbimazole therapy A Calañas-Continente, M Espinosa, G Manzano-García, R Santamaría, ... Thyroid 15 (3), 286-288, 2005 | 56 | 2005 |
| The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: keeping chronic kidney disease out of sight of health authorities will only magnify the problem A Ortiz, MD Sanchez-Niño, M Crespo-Barrio, P De-Sequera-Ortiz, ... Nefrología (English Edition) 39 (1), 29-34, 2019 | 54 | 2019 |
| Presión arterial y progresión de la enfermedad renal crónica R Santamaría Olmo, M Gorostidi Pérez NefroPlus 5 (1), 4-11, 2013 | 54 | 2013 |
| Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration JM Díaz-Tocados, ME Rodríguez-Ortiz, Y Almadén, C Pineda, ... Kidney International 95 (5), 1064-1078, 2019 | 46 | 2019 |
| Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial KR Tuttle, SJ Hauske, ME Canziani, ML Caramori, D Cherney, L Cronin, ... The Lancet 403 (10424), 379-390, 2024 | 44 | 2024 |
| Replicative senescence in patients with chronic kidney failure R Jimenez, J Carracedo, R Santamara, S Soriano, JJ Madueo, ... Kidney International 68, S11-S15, 2005 | 44 | 2005 |
alejandro martin maloProfessor of medicine University hospital Reina Sofia, Cordoba, Spain在 senefro.org 的电子邮件经过验证
